Ezeprogind

N/A

Report date: 2025/03/26 15:47:48
NME

Base Information

Drug NameEzeprogind
Drug Alias NameAZP-2006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlzprotectInserm
China Registration ClassN/A

Develop Information

Active CompaniesAlzprotect Sas
Inactive CompaniesAlzprotect
Active IndicationsSupranuclear Palsy, Progressive
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A